Torl Biotherapeutics, Llc
Clinical trials sponsored by Torl Biotherapeutics, Llc, explained in plain language.
-
First patients test experimental cancer drug in groundbreaking trial
Disease control OngoingThis is the first time researchers are testing the experimental drug TORL-3-600 in people. The study aims to find a safe dose and see how the body handles the drug in 70 patients with advanced solid tumors, including colorectal cancer. It is an early safety study, not a cure, and…
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
First patients test promising new weapon against tough cancers
Disease control OngoingThis is the first time a new drug called TORL-2-307-ADC is being tested in people. The main goal is to find a safe dose and see how the body handles it in 163 patients with advanced solid tumors, including stomach and pancreatic cancer. Researchers will also look for early signs …
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC